These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8659037)

  • 1. [Morphological factors in the prognosis of the treatment results in prostatic cancer].
    Murzaliev AD; Iiazaliev KT; Abdyldaev RA; Sizikov AI
    Urol Nefrol (Mosk); 1996; (1):22-5. PubMed ID: 8659037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The combined treatment of patients with locally disseminated prostatic cancer].
    Matveev BP; Iiazaliev KT
    Urol Nefrol (Mosk); 1993; (4):21-5. PubMed ID: 8310560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoma of the prostate: a single institutional review.
    Janet NL; May AW; Akins RS
    Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The late results of the combined hormonal chemoradiation treatment of prostatic cancer].
    Sviridova TV; Mardynskiĭ IuS; Tsodikova LB; Rozhkov OV
    Urol Nefrol (Mosk); 1996; (1):31-4. PubMed ID: 8659040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of gamma teletherapy of prostate cancer patients].
    Sviridova TV; Dunchik VN; Mardynskiĭ IuS; Tsodikova LB
    Med Radiol (Mosk); 1983 Nov; 28(11):15-20. PubMed ID: 6645824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparative efficacy of radiation and thermoradiation treatments in prostatic cancer].
    Tkachev SI; Bukharkin BV; Sholokhov VN; Klimakov BD
    Urol Nefrol (Mosk); 1996; (1):25-8. PubMed ID: 8659038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiation exposure and local hyperthermia in the treatment of prostatic cancer].
    Goldobenko GV; Tkachev SI; Matveev BP; Aliev BM; Bukharkin BV; Zhmarkin NI
    Urol Nefrol (Mosk); 1990; (4):35-8. PubMed ID: 2125765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
    Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
    Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
    Iwasawa T; Matsumoto H
    Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.